BCL2L1 and metastatic melanoma: For instance, the splicing of Bcl-x(L) in cancer cells can be redirected towards the pro-apoptotic variant Bcl-x(S), which has been shown to reduce the tumor load in xenografts of metastatic melanoma [70].